Oxford Biomedica PLC
OXB | IL
Overview
Corporate Details
- ISIN(s):
- GB00BDFBVT43
- LEI:
- 213800S1GVQNXQ15K851
- Country:
- United Kingdom
- Address:
- WINDRUSH COURT, OX4 6LT OXFORD
- Website:
- https://www.oxb.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Oxford Biomedica PLC is a UK-based gene and cell therapy company, providing innovative solutions for the development and manufacture of therapies.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-23 08:00 |
Regulatory News Service
OXB completes acquisition of US subsidiary
|
English | 12.3 KB | |
| 2025-06-17 19:00 |
Directors' Dealings
Director/PDMR Shareholding
|
English | 18.8 KB | |
| 2025-06-11 08:02 |
Business and Financial Review
AGM Update
|
English | 12.6 KB | |
| 2025-06-10 11:49 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 22.2 KB | |
| 2025-06-05 08:00 |
Regulatory News Service
Block Listing Application
|
English | 10.8 KB | |
| 2025-06-03 08:00 |
Regulatory News Service
OXB Launches Advisory Board
|
English | 21.4 KB | |
| 2025-06-02 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 10.8 KB | |
| 2025-05-16 18:52 |
Remuneration Report
Grant of options
|
English | 204.1 KB | |
| 2025-04-28 14:03 |
Annual Report (ESEF)
Annual financial and audit reports
|
English | 6.4 MB | |
| 2025-04-28 14:03 |
Annual Report
Annual financial and audit reports
|
English | 17.0 MB | |
| 2025-03-03 10:00 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 11.0 KB | |
| 2025-02-26 08:00 |
Regulatory News Service
OXB to present at Leerink Conference
|
English | 9.8 KB | |
| 2025-02-20 16:42 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 24.1 KB | |
| 2025-02-20 14:32 |
Regulatory News Service
OXB Lentiviral Vectors Used in Gene Therapy Trial
|
English | 13.7 KB | |
| 2025-02-20 14:13 |
Declaration of Voting Results & Voting Rights Announcements
Standard form for notification of major holdings
|
English | 29.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
PREDILIFE | France | ALPRE | |
|
PROSPEX ENERGY PLC | United Kingdom | PXEN | |
|
Prostatype Genomics AB | Sweden | PROGEN | |
|
Psych Capital Plc | United Kingdom | PSY | |
|
Pure Biologics S.A. | Poland | PUR | |
|
Puretech Health PLC | United States of America | PRTC | |
|
Purple Biotech Ltd. | Israel | PPBT | |
|
QLife Holding AB | Sweden | QLIFE | |
|
Quantum Genomics | France | ALQGC | |
|
QUIA PHARMA AB | Sweden | QUIA |